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The nicotinic synapse has been a
touchstone for advances in neuro-
science ever since Jean Nicot, the
French ambassador to Portugal, sent
some tobacco seeds home to Paris in
1550 with a note that the New World
plant had interesting effects when
smoked. Now the muscle nicotinic
acetylcholine receptor (nAChR) is a
well-studied example of ligand-gated
ion channels. After a motor neuron is
stimulated, the nerve impulse reaches
the presynaptic terminal, where it
evokes release of acetylcholine (ACh)
into the synapse. The nAChR depolar-
izes the postsynaptic muscle and trig-
gers muscle action potentials; muscle
contraction follows. To date, several
nAChR subtypes have been success-
fully isolated, purified, imaged, and
expressed, and unitary currents have
been recorded from these channels
(1). Researchers continue to unravel
the molecular mechanisms of these
macromolecules that are embedded in
membranes at vertebrate nerve-mus-
cle synapses, at invertebrate nicotinic
synapses (which explains why nico-
tine-producing tobacco plants have a
select advantage against invertebrate
pests), and in the vertebrate central
system (which explains Jean Nicot’s
fascination with those leaves). Howev-
er, the precise structural events that
trigger channel opening or “gating”
remain mostly unknown.
Site-directed mutagenesis reveals
some information about nAChR func-
tion but fails to give us an appreciation
for the physiological significance of the
receptor’s biophysical properties. Dur-
ing the last decade, the venerable phar-
macological approaches have been
aided by newer insights from molecular
genetics. We now appreciate that a
number of naturally occurring muta-
tions within nAChRs lead to severe dis-
orders. These ion-channel–associated
disorders are collectively known as
channelopathies. The nAChR is a het-
eropentamer assembled from α, β, γ, 
(or ε) and δ subunits (Figure 1). Each 
subunit is thought to contain a large 
N-terminal domain, followed by four
transmembrane regions (M1–M4) with
a large cytoplasmic loop between M3
and M4. In the central nervous system,
at least five mutations linked to auto-
somal dominant nocturnal frontal lobe
epilepsy lie within, or immediately adja-
cent to, M2 — the putative pore-form-
ing region of neuronal nAChR subunits
(2, 3). At the nerve-muscle synapse, at
least 26 mutations in the extracellular,
transmembrane, and cytoplasmic do-
mains of the nAChR lead to different
forms of congenital myasthenic syn-
drome (CMS) (4, 5). Thus these clinical
cases aid in assigning physiological
functions to the biophysical properties
of nicotinic receptors.
In this issue of the JCI, Shen and col-
leagues report the channel kinetics
from a valine to leucine mutation
(V132L) located in the α subunit of the
muscle nAChR within the signature
cystine loop (cys-loop) (6). The cys-loop
is a highly conserved structure found
in every subunit of the ligand-gated ion
channel superfamily. In a high-resolu-
tion structural model of the nAChR 
N-terminus, based on the crystal struc-
ture of a snail (Lymnae stagnalis) acetyl-
choline-binding protein (AChBP), the
cys-loop is located near the membrane
surface (highlighted in red in Figure 1).
Sequence analysis reveals that the
AChR cys-loop contains a higher pro-
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Figure 1
The structure of AChBP is illustrated over a representation of the transmembrane domain of nAChR.
Each subunit (α, β, γ or ε, δ) is labeled by its Greek symbol. The α subunit is shown in yellow, except
for most of the signature cys-loop, which is shown in red, and AChBP G127 is shown in green (this
residue aligns with nAChRα V132). The membrane spanning regions M1–M3 are represented on
the bilayer surface, and M4 is also shown in cross section.
portion of hydrophobic residues than
the AChBP loop (7, 8). Furthermore,
cryoelectron microscopy imaging of
Torpedo electroplax membranes en-
riched with nAChR suggests that the
cys-loop resides near the second (M2)
and third (M3) transmembrane do-
mains, where it may couple agonist
binding to channel activation (8, 9).
The αV132L mutation leads to a severe
form of postsynaptic CMS. Postsynaptic
CMS mutations are classified as either
slow- (SCCMS) or fast-channel congen-
ital myasthenic syndromes (FCCMS),
depending on their effects on the ampli-
tude and waveform of postsynaptic cur-
rents at the muscle membrane. SCCMS
mutations en-hance agonist affinity or
gating efficiency. FCCMS mutations
reduce agonist affinity for the open
channel or impair gating (4). In the pres-
ent manuscript, the authors detail the
detrimental effects of a FCCMS muta-
tion on ACh binding and channel gating
(6). Similar to other FCCMS mutations,
αV132L attenuates the postsynaptic
response to ACh. Specifically, αV132L
reduces ACh binding affinity for the
closed channel state by 30-fold. Conse-
quently, ACh released into the synaptic
space is predicted to activate only 10% of
the available binding sites, much less
than normal. Moreover, there is a five-
fold decrease in the total ACh current
due to an accelerated decay of the synap-
tic response. In short, receptors contain-
ing the αV132L mutation have patho-
logically little activation, and that for
pathologically brief periods. This would
be consistent with weak or nonexistent
muscle stimulation in response to motor
neuron activity.
Do subunits with homologous
sequences look alike?
Interestingly, amino acid substitutions
at positions corresponding to αV132L
in the β, ε, and δ subunits yielded sig-
nificantly different phenotypes (6). Sub-
stitution of the aligning V residue in the
β and ε subunits produces virtually no
effect, while substitution in the δ sub-
unit produces a receptor with nearly the
opposite phenotype of αV132L. Specif-
ically, δV134L has slight effects on ACh
binding affinity, but gating efficiency is
reduced nearly fourfold. We suspect
that each subunit’s signature cys-loop
folds and functions in a generally simi-
lar manner, but there is clearly some
functional and struc-tural asymmetry at
a more detailed level. Indeed, based on
cryoelectron microscopy studies of the
Torpedo nAChR in the open state (9),
individual subunits do assume asym-
metrical conformations and presum-
ably have unique local environments.
Apparently, even a small structural per-
turbation may lead to asymmetric
changes in function.
Implications from CMS studies
Progress continues into the 21st cen-
tury. Shen and colleagues, including
the Sine and Auerbach labs, are con-
tributing to the study of the molecu-
lar pathophysiology of CMS. Further-
more, their biophysical analyses of the
CMS mutations have provided us
with some basic insights into the rela-
tionship between the structure and
function of nAChRs. However, we still
await refined structural information
on the nAChR ion channel in order to
further exploit present gating predic-
tions based on similar kinetic studies.
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